Evidence map›Paper›PMID 41057745›Full record

ArticleAnnals of surgical oncology2026

Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg.

Paula Marincola Smith, Koichi Tomita, Samuel Cass, Yuki Hirata, Cong Pan, Shu-En Shen, Xuemei Wang, Xin Shelley Wang, Loretta A Williams, Melissa Arvide and 18 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Paula Marincola SmithDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Koichi TomitaDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Samuel CassDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yuki HirataDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cong PanDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shu-En ShenDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xuemei WangDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xin Shelley WangDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Loretta A WilliamsDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Melissa ArvideDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Connie ToDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ravi RajaramDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David RiceDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wayne HofstetterDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mara AntonoffDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reza MehranDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ara VaporciyanDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garrett WalshDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jessica MaxwellDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rebecca SnyderDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michael KimDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ching-Wei D TzengDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brian BadgwellDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Paul MansfieldDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matthew KatzDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stephen SwisherDepartment of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey LeeDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Naruhiko IkomaDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. nikoma@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe MD Anderson Symptom Inventory (MDASI) is a well-established, validated patient-reported outcome survey that assesses cancer patient symptom burden for use in clinical care and research. Multiple MDASI modules have been developed and validated to tailor the survey to specific cancer/treatment types. We validated an MDASI survey specific to surgical patients with upper gastrointestinal (UGI) cancers (MDASI-UGI-Surg), including pancreatic and gastroesophageal cancers, and which is designed to capture dynamic changes in symptom burden in the perioperative period.

methodsFollowing qualitative interviews and expert panel feedback, the MDASI-UGI-Surg module was developed and validated in 169 consecutive patients undergoing major surgical resection for UGI cancer. Surveys were administered preoperatively as well as 3, 7, 14, 21, and 28 days postoperatively, and again 24 hours later to measure test-retest reliability. Outcome measures were validity and reliability.

resultsA total of 145 patients enrolled were deemed evaluable (6 patients withdrew, 18 operations were cancelled/aborted). Disease sites included 42 (28.97%) esophagus, 27 (18.62%) stomach, and 76 (52.41%) pancreas. Cronbach alpha was 0.79 and 0.92 for symptoms severity items and interference items, respectively. Known-group validity was supported by the ability of MDASI-UGI-Surg to detect significant differences in symptom and interference levels according to performance status. Test-retest reliability was confirmed with intraclass correlation (0.76 to 0.89). Composite scores for core, module, and interference items were not significantly different between patients from the three disease sites of interest.

conclusionsThe MDASI-UGI-Surg is a new, psychometrically validated tool that can be used to capture dynamic changes in symptom burden in UGI cancer patients.

Indexed as

Esophageal NeoplasmsGastrointestinal NeoplasmsPancreatic NeoplasmsPatient Reported Outcome MeasuresPsychometricsQuality of LifeAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisReproducibility of ResultsMD Anderson Symptom Inventory (MDASI)Patient Reported Outcomes (PRO)Quality of LifeUpper Gastrointestinal CancerValidation

Identifiers

PMID41057745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.